Structure Stock Soars. Its Obesity Pill Could Challenge Lilly, Novo.
Analysts say that the arrival of cheaper, more convenient obesity pills could mean much broader access for patients, and eventually a larger market.
Source: marketwatch.com
📰 Structure Thereapeutics News
Structure Thereapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Structure Thereapeutics. Real-time updates on events, politics, business and more.